Skip to main content
PMC home page
Nutrients logoLink to Nutrients
. 2019 Aug 20;11(8):1952. doi: 10.3390/nu11081952

Role of Glutathionylation in Infection and Inflammation

Paola Checconi 1,*,†, Dolores Limongi 1,†, Sara Baldelli 1, Maria Rosa Ciriolo 1,2, Lucia Nencioni 3,†, Anna Teresa Palamara 1,3,†
PMCID: PMC6723385  PMID: 31434242

Abstract

Glutathionylation, that is, the formation of mixed disulfides between protein cysteines and glutathione (GSH) cysteines, is a reversible post-translational modification catalyzed by different cellular oxidoreductases, by which the redox state of the cell modulates protein function. So far, most studies on the identification of glutathionylated proteins have focused on cellular proteins, including proteins involved in host response to infection, but there is a growing number of reports showing that microbial proteins also undergo glutathionylation, with modification of their characteristics and functions. In the present review, we highlight the signaling role of GSH through glutathionylation, particularly focusing on microbial (viral and bacterial) glutathionylated proteins (GSSPs) and host GSSPs involved in the immune/inflammatory response to infection; moreover, we discuss the biological role of the process in microbial infections and related host responses.

Keywords: glutathione, glutathionylation, redox signaling, infection, inflammation

1. Introduction

Glutathione, Cellular Thiols, and Glutathionylation

The tripeptide γ-l-glutamyl-l-cysteinyl-glycine, or glutathione (GSH), is the most abundant eukaryotic intracellular thiol, found in a concentration range of 1–10 mM. It is mainly localized in the cytosol (up to 90%), but it is also present in the mitochondria (10%), the endoplasmic reticulum, and the nucleus in a small percentage [1]. The antioxidant activity of GSH is probably the best known and popular function of this molecule; in fact, thanks to the reactivity and the reducing ability of its cysteinyl residue’s sulfhydryl (-SH) group, it can quickly react with and neutralize potentially dangerous molecules, both of endogenous and exogenous origin, as reactive oxygen and nitrogen species (ROS and RNS, respectively), xenobiotics, and metals [2].

However, today it is well known that the essential role of GSH overcomes its scavenger activity and it plays a crucial role in cell fate, regulating processes such as proliferation, differentiation, and apoptosis, and several other cellular functions, ranging from metabolism to immune and inflammatory response [3,4,5,6]. In fact, the concentration of GSH and its oxidized form, glutathione disulfide (GSSG), mainly determines the redox state of the cell. Together with other thiol redox couples, such as Trx-SH/Trx-SS, GSH/GSSG acts as a sensor of intracellular redox changes and couples these modifications to redox-dependent biochemical processes [7]. What are the mechanisms by which GSH/GSSG plays a role in signaling? Keeping in mind that the GSH/GSSG couple is the main determinant of H2O2 level, which is a well-known intracellular messenger in signal transduction (see reviews [8,9,10,11,12,13]), it can play a direct role in signaling through glutathionylation, that is, the formation of mixed disulfides between its cysteine and the cysteine of a protein [14]. As for the processes regulated by phosphorylation, the redox-mediated signal impacts proteins through a specific amino acid residue (i.e., cysteine). Several modifications of the thiol group can occur for structural needs, such as inter/intrachain disulfide –SS–, or different degrees of oxidative stress, such as the sulfenic –SOH, sulfinic –SO2H, sulfonic –SO3H, and mixed disulfide with cysteine or glutathione –SSR [15]. A prerequisite for cysteine residue modification is its accessibility by the solvent and a peculiar reactivity imposed by near amino acids. Indeed, the pK value of the cysteine thiol group is around 8.0 and, therefore, always protonated at physiological pH. The so-called “reactive cysteine”, instead, is localized in a basic milieu that stabilizes the thiolated form –S− and represents a very reactive group. The formation of glutathionylated proteins (GSSPs) has been known for many years. Initially considered an effect of oxidative stress and damage [16,17], it then became clear that it occurred also under physiological conditions and, being a reversible process, could have a role in redox signaling [18,19,20]. GSSPs can be formed by different biochemical reactions: through the formation of sulfenic acids (reaction below (1)) or the thiol–disulfide exchange that occurs between GSSG and protein thiols (2). The reaction can be reversibly catalyzed by different enzymes belonging to the family of thiol–disulfide oxidoreductases or redoxins, including glutaredoxin (Grx) [21], where reversibility and catalysis are important requirements for the regulatory role of the process [22,23].

(1) PSOH + GSH ⇄ GSSP + H2O
(2) PSH + GSSG ⇄ GSSP + GSH
redoxins

It is known that several proteins undergo glutathionylation, resulting in different biological effects [23,24]. Most studies on the identification of glutathionylated proteins have focused on cellular proteins, including proteins involved in host response to infections, but there is a growing number of reports showing that microbial proteins also undergo glutathionylation [25].

Therefore, this review is an attempt to highlight the signaling role of GSH through glutathionylation, particularly focusing on microbial GSSPs and host GSSPs involved in the immune/inflammatory response to infection.

2. Glutathionylation in Infections

2.1. Viral Infections

It is well known that viruses alter the intracellular redox state to pro-oxidant conditions, which is an alteration that contributes to viral pathogenesis [26,27,28,29,30,31]. Thus, researchers have been evaluating redox signaling as a potential target for antiviral strategies [32,33,34,35,36,37,38]. Virus-induced redox imbalance has been measured in terms of ROS overproduction and/or GSH depletion in different viral infections, with different kinetics and mechanisms according to the type of virus and cell host [39,40,41,42,43,44,45,46]. Based on what has been discussed so far—protein glutathionylation is a physiological process amplified by oxidative stress, and viruses induce a redox imbalance towards a pro-oxidant state—it is not surprising to wonder if glutathionylated proteins are detectable during viral infections and if viral proteins themselves undergo glutathionylation.

The first evidence for viral protein glutathionylation was provided by Davis et al. in 1996 [47]. In fact, they showed that HIV protease contains two cysteines, which are highly conserved among clinical isolates, that could form mixed disulfides with low-molecular-weight (LMW) thiols, including GSH, and that this post-translational modification changes the enzyme activity [47]. HIV protease activity could be regulated through the glutathionylation of these two conserved cysteines by human thioltransferase or glutaredoxin, which has been detected in HIV virions [48]. So, the fine regulation of protease activity may promote optimal viral replication [49]. Interestingly, the finding that the protease of another retrovirus, HTLV-1, could be regulated by reversible oxidation in a similar way to that observed for HIV protease led to the idea that this could be an important evolutionarily conserved mechanism that could prevent the premature activation of retroviral proteases in infected cells—detrimental for the cells and the virus—and promote their activation later in the virus life cycle at the optimal timing for viral maturation and budding [50]. More recently, glutathionylation of chikungunya virus nsP2 protein has been described [51]. In particular, both the recombinant protein and the viral protein in chikungunya-infected cells have been shown to undergo glutathionylation. Interestingly, as well as retrovirus proteases, the glutathionylated protein showed lower protease activity, although the six cysteines identified as being glutathionylated are not in the protease active site. This suggested that glutathionylation induces conformational changes in the protein that can also affect sites far from those that have been glutathionylated, and in this way, affect protein function. Moreover, and again in a similar way to that observed in retrovirus, the specific timing in which the authors observed the modification suggests that the glutathionylation/deglutathionylation process switches the protein function for the progression of the virus life cycle. The same authors showed that dengue and Zika NS5 proteins were glutathionylated in three cysteines and that the post-translational modification reduced the guanylyltransferase activity of the enzyme from both viruses. The fact that the cysteines found to be glutathionylated are highly conserved across more flaviviruses also led these authors to suggest that glutathionylation may be a general mechanism for this family of viruses to regulate NS5 activities. However, how this modification alters the multiple other functions of the protein and how this could affect viral replication remain to be elucidated [52]. Finally, we have data (Checconi et al., unpublished) supporting the glutathionylation of influenza virus proteins that led us to strongly share the hypothesis that the glutathionylation/deglutathionylation process could be an important, common mechanism of redox regulation in the replication of more families of viruses.

The cellular redox proteome responds through modifications, in particular of cysteines, to environmental challenges, such as viruses [53]. Glutathionylation of cellular proteins during viral infections has been reported since 1997. Indeed, Ciriolo et al. [42] measured a significant amount of glutathione-mixed disulfides in epithelial cells infected by Sendai, a parainfluenza virus [42]. Ghezzi et al. [54] measured the rate of protein glutathionylation/deglutathionylation in HIV-infected T lymphocytes, showing that HIV infection made the dethiolation process slower, and the effect was reverted by the addition of the antioxidant N-acetylcysteine (NAC) [54]. Subsequent studies identified several of these proteins that undergo glutathionylation during viral infections; interestingly, some of them belong to pathways involved in the cellular response to infection. It has been reported that interferon regulatory factor 3 (IRF3) is deglutathionylated by Grx during Sendai virus infection to efficiently activate the transcription of interferon genes and therefore the innate immune response to the virus [55]. In the same line, it has been shown that HSV infection induced the production of ROS that mediate the glutathionylation of proteins belonging to the TRAF family, in particular, TRAF3 and TRAF6, which are essential for the proper activation of the antiviral innate immune response [56]. Among the functions influenced by the cysteine proteome, there is also protein secretion [57]. Thanks to a redox proteomic technique based on the use of biotinylated glutathione, a set of proteins, including redoxins such as peroxiredoxins (PRDXs) and thioredoxin (TRX), was found by our group to be released in glutathionylated form by lipopolisaccharide (LPS)-stimulated macrophages and influenza-virus-infected cells [31]. We can speculate that these GSSPs could have a role in the pathogenesis of influenza, as PRDX2 has been demonstrated to be a danger signal in an inflammatory setting [58]. Moreover, a redistribution of key antioxidant enzymes, including PRDX6, in lung cell types was already observed during influenza pneumonia in mice [59]. Thioredoxin deserves special attention, as it is a redox enzyme that has long been studied in the context of infection and inflammation [60,61], including those from influenza virus. In particular, Go et al. [62] demonstrated that TRX1 localization in cell nuclei increased the severity of the disease and lethality in influenza-virus-infected mice by activation of redox-sensitive inflammatory transcription factors; on the other hand, the overexpression of TRX or the administration of recombinant TRX, or a serum albumin-TRX fusion protein, in mice has been shown to ameliorate the outcome of influenza virus lung injury [63,64,65]. These apparent opposite results indicate the importance of redox compartmentalization [66] and suggest that reductive stress, as well as oxidative stress, can contribute to disease mechanisms due to the disruption of redox signaling and control, more so than the increase in reducing or oxidizing species themselves.

Finally, it must be borne in mind that a significant proportion of the “immunopeptidome”, that is, the peptides stimulating immune cells, have been shown to contain glutathionylated cysteines, with consequences for antigen presentation/T-cell recognition. It has been reported that glutathionylation of a coronavirus peptide reduced CD8 T-cell recognition, so this could be a redox mechanism for the virus to negatively impact the immune response [67].

2.2. Bacteria

Growing evidence highlights the importance of LMW thiols and GSH in bacteria [25,68]. GSH is present in Gram-negative and some Gram-positive bacteria (i.e., Listeria monocytogenes and Streptococcus agalactiae), while other Gram-positive bacteria produce LMW thiols, such as bacillithiol (BSH) and mycothiol (MSH), with similar functions. These functions, as in eukaryotic cells, include detoxification of different reactive species to maintain the redox balance of the bacteria cytoplasm. Recently, however, the direct role of GSH in virulence has been described for different bacteria. For example, it has been shown that GSH activates virulence gene expression in the intracellular pathogen L. monocytogenes [69]. Similarly, BSH has been shown to be involved in the virulence of some clinical isolates of methicillin-resistant Staphylococcus aureus [70,71], and MSH is essential for the growth and survival of Mycobacterium tuberculosis during infection [72].

Thanks to advances in proteomic studies, a growing number of bacteria proteins have been identified to be S-glutathionylated, S-bacillithiolated, or S-mycothiolated, making it plausible that S-thiolation could be the mechanism of redox regulation for these proteins. In Salmonella typhimurium, a top-down proteomic approach identified over 500 proteins with 1665 post-translational modifications, among which 25 were s-thiolation. Interestingly, nine s-glutathionylated proteins switched to s-cysteinylation under infection-like conditions, suggesting that this shift could be a novel redox mechanism of infection control [73]. Portman et al. [74] demonstrated that the cytolysin listeriolysin O (LLO), a pore-forming virulence factor of L. monocytogenes, is reversibly inhibited by glutathionylation. Interestingly, a mutant of LLO unable to undergo this post-translational modification was less virulent in vivo, suggesting that the modification could be important to restrict the pore-forming capability to an appropriate temporal and/or spatial compartment during infection.

Regarding cellular proteins involved in the response to bacterial infection, the death receptor Fas, known to be activated by several pathogens, including Pseudomonas aeruginosa, has been shown to be glutathionylated after caspase-dependent cleavage of Grx1. Glutathionylation of Fas then resulted in an amplification of apoptosis [75]. In a subsequent study, the same authors demonstrated Fas glutathionylation in patients with P. aeruginosa pneumonia, showing that the modification promoted bacteria clearance. Overall, these results indicate the importance of the Grx1/Fas glutathionylation axis in the resolution of the disease [76]. Recently, it was found that GSH metabolism affects host cytokine production in response to Borrelia burgdorferi infection, possibly through glutathionylation. Moreover, GSH-related metabolites have been found to be altered in patients with early onset of Lyme disease and these alterations persist for months after primary infection. Thus, it has been suggested that GSH metabolism and glutathionylation could be important processes in the pathogenesis of the B. burgdorferi-induced Lyme disease and, potentially, other inflammatory diseases as well [77].

3. Glutathionylation in Inflammation

The final section of this review is dedicated to a brief analysis of glutathionylation in inflammation, focusing on nuclear factor kappa β transcription factor (NFκB)’s glutathionylation.

NFκB is a transcription factor that plays an important role in the activation of proinflammatory response. Under physiological conditions, NFκB is sequestered in the cytoplasm in a latent form by inhibitor κB (IκB). After phosphorylation by IκB kinase (IKK), IκB undergoes degradation via proteasomes and NFκB is then free to move into the nucleus, where it induces transcription of proinflammatory genes. Various studies have shown that glutathionylation, through the bond of GSH to the DNA binding domain, is able to regulate the activity of many transcription factors, including NFκB [78,79]. In particular, the p65 subunit of NFκB has been reported to be glutathionylated in different conditions, such as after supplementation of GSH, which leads to DNA binding inhibition [79]. It has been also demonstrated that the treatment of endothelial cells with an electrophilic compound (cinnamaldehyde) induced p65-glutathionylation, leading to the inhibition of TNF-α-induced p65 nuclear translocation and ICAM-1 expression [80]. During treatment with cinnamaldehyde, the authors also observed an increase of Grx1 protein level. The downregulation of Grx1 abolished p65-glutathionylation and blocked the inhibition of its nuclear translocation and ICAM-1 expression, suggesting that the enzyme is involved in cinnamaldehyde-mediated NFκB inhibition. In a subsequent study, it was shown that treatment with another electrophilic compound, 15-deoxy-Δ12,14-prostaglandin J (2) (15d-PGJ (2)), caused p65-glutathionylation, again suppressing p65 nuclear translocation and the expression of ICAM-1, thus working as an anti-inflammatory molecule [81]. Treatment of hepatocytes with H2O2 also induced p65-glutathionylation and its retention in the cytoplasm, leading to an increase of the apoptotic rate of hepatocytes [82]. Besides p65, S-glutathionylation was also observed for the p50 subunit of NFκB on Cys-62. This post-translational modification reversibly inhibited its DNA binding activity [83].

Moreover, IKK, the protein responsible for IκB phosphorylation and NFκB translocation to the nucleus, can be inactivated by S-glutathionylation of Cys-179 [84]. So, the NFκB complex, as well as upstream proteins such as TRAF6, is negatively regulated via glutathionylation [85]. In these two studies, it was shown that knockdown of Grx1 hampered IKK and TRAF6 deglutathionylation, respectively, and reduced NFκB activation, indicating the importance of Grx1-mediated deglutathionylation in modulating the NFκB signaling pathway [85]. Moreover, both p65 and IKKa have been shown to be regulated by the Grx1/glutathionylation axis in IL-17A-stimulated epithelial cells, contributing to IL-17A-induced proinflammatory response [86].

Jones et al. [87] demonstrated that glutathione S-transferase (GSTP) is another enzyme capable of inducing the S-glutathionylation of many proteins under conditions of oxidative stress. The authors highlighted that, in unstimulated cells, GSTP bound the NFκB inhibitor, IκBα, while exposure to LPS led to their dissociation. LPS treatment also induced GSTP association with IKKβ and IKKβ-S-glutathionylation to increase. The inhibition of GSTP with siRNA, causing a decrease in IKKβ-S-glutathionylation, enhanced NFκB nuclear translocation, its transcriptional activity, and production of proinflammatory cytokines [87].

Finally, we have to mention that interleukin-1β, together with a group of cytokines, has been shown to undergo glutathionylation itself [88]. In particular, the authors demonstrated that IL-1β glutathionylation at the conserved cysteine Cys-188 protected it from ROS deactivation, making it necessary for maintaining cytokine bioactivity. Grx1 is the physiological negative regulator of the glutathionylation process, and it has been suggested to be a new potential therapeutic target in the treatment of various infectious and inflammatory diseases.

Figure 1 is a schematic picture of the glutathionylated proteins described in this review, and Figure 2 summarizes the effects of glutathionylation on those proteins.

Figure 1.

Figure 1

Open in a new tab

Biochemical reactions through which glutathionylated proteins can be formed and a list of proteins that have been shown to undergo glutathionylation in viruses (a), bacteria (b), or cellular immune/inflammatory pathways (c).

Figure 2.

Figure 2

Open in a new tab

Diagram summarizing the effect or biological role, known or proposed, of glutathionylation on proteins described in this review, including the relevant references.

4. Conclusions

In this review, we underscored the role of glutathionylation in viral/bacterial infections and host response. It is well known that infections, particularly viral infections, cause a redox imbalance towards pro-oxidant conditions in the cell, and we believe that glutathionylation fits into these virus-induced changes to regulate its replication and/or cell response. However, based on the available knowledge, we may speculate that the glutathionylation/deglutathionylation process is not a mere consequence of the oxidative burst but a finer regulation of the different phases of viral replication. In particular, glutathionylation could inhibit the premature activation of some viral protein functions, as in the case of retroviral proteases, which would be harmful for the cells and the virus and promote their activation at the optimal timing for viral maturation and spread. In a similar way, the process could play a role in bacterial infections, representing a potential mechanism of virulence. At the same time, the inflammatory cell response to infections could be affected, for example, by the redox processes regarding NFκB activation. This nuclear transcription factor was among the first identified to be redox modulated and strictly involved in inflammation, viral replication, and cell proliferation/apoptosis. The transient glutathionylation of NFκB could also take part in the regulatory processes committed by infections.

Overall, a deeper knowledge of the chemical and regulatory processes through which glutathionylation occurs could pave the way for the identification of novel targets to control microbial infections and related host responses.

Author Contributions

P.C. and D.L. literature search, draft preparation, writing and editing of the manuscript, equally contributions to the work; S.B., M.R.C., L.N. and A.T.P. reviewing and editing; L.N. and A.T.P. supervision and funding acquisition.

Funding

This work was partially supported by the Italian Ministry of Instruction, Universities and Research—MIUR PRIN 2017KM79NN (PC), PRIN 2017WJBKKW (DL), Ateneo 2016 and MIUR PRIN 2017BMK8JR006 (ATP, LN) grants.

Conflicts of Interest

The authors declare no conflict of interest.

References

  • 1.Meister A. On the discovery of glutathione. Trends Biochem. Sci. 1988;13:185–188. doi: 10.1016/0968-0004(88)90148-X. [DOI] [PubMed] [Google Scholar]
  • 2.Dickinson D.A., Forman H.J. Cellular glutathione and thiols metabolism. Biochem. Pharmacol. 2002;64:1019–1026. doi: 10.1016/S0006-2952(02)01172-3. [DOI] [PubMed] [Google Scholar]
  • 3.Forman H.J., Zhang H., Rinna A. Glutathione: Overview of its protective roles, measurement, and biosynthesis. Mol. Asp. Med. 2009;30:1–12. doi: 10.1016/j.mam.2008.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Aquilano K., Baldelli S., Ciriolo M.R. Glutathione: New roles in redox signaling for an old antioxidant. Front. Pharmacol. 2014;5:196. doi: 10.3389/fphar.2014.00196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Fratelli M., Goodwin L.O., Orom U.A., Lombardi S., Tonelli R., Mengozzi M., Ghezzi P. Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc. Natl. Acad. Sci. USA. 2005;102:13998–14003. doi: 10.1073/pnas.0504398102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Diotallevi M., Checconi P., Palamara A.T., Celestino I., Coppo L., Holmgren A., Abbas K., Peyrot F., Mengozzi M., Ghezzi P. Glutathione fine-tunes the innate immune response toward antiviral pathways in a macrophage cell line independently of its antioxidant properties. Front. Immunol. 2017;8:1239. doi: 10.3389/fimmu.2017.01239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 2001;30:1191–1212. doi: 10.1016/S0891-5849(01)00480-4. [DOI] [PubMed] [Google Scholar]
  • 8.Rhee S.G., Kang S.W., Jeong W., Chang T.S., Yang K.S., Woo H.A. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 2005;17:183–189. doi: 10.1016/j.ceb.2005.02.004. [DOI] [PubMed] [Google Scholar]
  • 9.Forman H.J., Maiorino M., Ursini F. Signaling functions of reactive oxygen species. Biochemistry. 2010;49:835–842. doi: 10.1021/bi9020378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Marinho H.S., Real C., Cyrne L., Soares H., Antunes F. Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol. 2014;2:535–562. doi: 10.1016/j.redox.2014.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox Biol. 2017;11:613–619. doi: 10.1016/j.redox.2016.12.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Di Marzo N., Chisci E., Giovannoni R. The role of hydrogen peroxide in redox-dependent signaling: Homeostatic and pathological responses in mammalian cells. Cells. 2018;7:156. doi: 10.3390/cells7100156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Finkel T. Signal transduction by reactive oxygen species. J. Cell Biol. 2011;194:7–15. doi: 10.1083/jcb.201102095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Fratelli M., Demol H., Puype M., Casagrande S., Eberini I., Salmona M., Bonetto V., Mengozzi M., Duffieux F., Miclet E., et al. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc. Natl. Acad. Sci. USA. 2002;99:3505–3510. doi: 10.1073/pnas.052592699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Filomeni G., Rotilio G., Ciriolo M.R. Disulfide relays and phosphorylative cascades: Partners in redox-mediated signaling pathways. Cell Death Differ. 2005;12:1555–1563. doi: 10.1038/sj.cdd.4401754. [DOI] [PubMed] [Google Scholar]
  • 16.Brigelius R., Lenzen R., Sies H. Increase in hepatic mixed disulphide and glutathione disulphide levels elicited by paraquat. Biochem. Pharmacol. 1982;31:1637–1641. doi: 10.1016/0006-2952(82)90393-8. [DOI] [PubMed] [Google Scholar]
  • 17.Brigelius R., Muckel C., Akerboom T.P., Sies H. Identification and quantitation of glutathione in hepatic protein mixed disulfides and its relationship to glutathione disulfide. Biochem. Pharmacol. 1983;32:2529–2534. doi: 10.1016/0006-2952(83)90014-X. [DOI] [PubMed] [Google Scholar]
  • 18.Sies H., Brigelius R., Graf P. Hormones, glutathione status and protein S-thiolation. Adv. Enzym. Regul. 1987;26:175–189. doi: 10.1016/0065-2571(87)90013-6. [DOI] [PubMed] [Google Scholar]
  • 19.Giustarini D., Rossi R., Milzani A., Colombo R., Dalle-Donne I. S-glutathionylation: From redox regulation of protein functions to human diseases. J. Cell. Mol. Med. 2004;8:201–212. doi: 10.1111/j.1582-4934.2004.tb00275.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ghezzi P., Bonetto V., Fratelli M. Thiol-disulfide balance: From the concept of oxidative stress to that of redox regulation. Antioxid. Redox Signal. 2005;7:964–972. doi: 10.1089/ars.2005.7.964. [DOI] [PubMed] [Google Scholar]
  • 21.Lillig C.H., Berndt C. Glutaredoxins in thiol/disulfide exchange. Antioxid. Redox Signal. 2013;18:1654–1665. doi: 10.1089/ars.2012.5007. [DOI] [PubMed] [Google Scholar]
  • 22.Shelton M.D., Chock P.B., Mieyal J.J. Glutaredoxin: Role in reversible protein s-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid. Redox Signal. 2005;7:348–366. doi: 10.1089/ars.2005.7.348. [DOI] [PubMed] [Google Scholar]
  • 23.Ghezzi P. Protein glutathionylation in health and disease. Biochim. Biophys. Acta. 2013;1830:3165–3172. doi: 10.1016/j.bbagen.2013.02.009. [DOI] [PubMed] [Google Scholar]
  • 24.Pastore A., Piemonte F. S-Glutathionylation signaling in cell biology: Progress and prospects. Eur. J. Pharm. Sci. 2012;46:279–292. doi: 10.1016/j.ejps.2012.03.010. [DOI] [PubMed] [Google Scholar]
  • 25.Dalle-Donne I., Rossi R., Colombo G., Giustarini D., Milzani A. Protein S-glutathionylation: A regulatory device from bacteria to humans. Trends Biochem. Sci. 2009;34:85–96. doi: 10.1016/j.tibs.2008.11.002. [DOI] [PubMed] [Google Scholar]
  • 26.Beck M.A., Handy J., Levander O.A. The role of oxidative stress in viral infections. Ann. N. Y. Acad. Sci. 2000;917:906–912. doi: 10.1111/j.1749-6632.2000.tb05456.x. [DOI] [PubMed] [Google Scholar]
  • 27.Akaike T. Role of free radicals in viral pathogenesis and mutation. Rev. Med. Virol. 2001;11:87–101. doi: 10.1002/rmv.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ivanov A.V., Valuev-Elliston V.T., Ivanova O.N., Kochetkov S.N., Starodubova E.S., Bartosch B., Isaguliants M.G. Oxidative stress during HIV infection: Mechanisms and consequences. Oxidative Med. Cell. Longev. 2016;2016:8910396. doi: 10.1155/2016/8910396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Limongi D., Baldelli S. Redox imbalance and viral infections in neurodegenerative diseases. Oxidative Med. Cell. Longev. 2016;2016:6547248. doi: 10.1155/2016/6547248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Anticoli S., Amatore D., Matarrese P., De Angelis M., Palamara A.T., Nencioni L., Ruggieri A. Counteraction of HCV-induced oxidative stress concurs to establish chronic infection in liver cell cultures. Oxidative Med. Cell. Longev. 2019;2019:6452390. doi: 10.1155/2019/6452390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Checconi P., Salzano S., Bowler L., Mullen L., Mengozzi M., Hanschmann E.M., Lillig C.H., Sgarbanti R., Panella S., Nencioni L., et al. Redox proteomics of the inflammatory secretome identifies a common set of redoxins and other glutathionylated proteins released in inflammation, influenza virus infection and oxidative stress. PLoS ONE. 2015;10:e0127086. doi: 10.1371/journal.pone.0127086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sgarbanti R., Nencioni L., Amatore D., Coluccio P., Fraternale A., Sale P., Mammola C.L., Carpino G., Gaudio E., Magnani M., et al. Redox regulation of the influenza hemagglutinin maturation process: A new cell-mediated strategy for anti-influenza therapy. Antioxid. Redox Signal. 2011;15:593–606. doi: 10.1089/ars.2010.3512. [DOI] [PubMed] [Google Scholar]
  • 33.Nencioni L., Sgarbanti R., Amatore D., Checconi P., Celestino I., Limongi D., Anticoli S., Palamara A.T., Garaci E. Intracellular redox signaling as therapeutic target for novel antiviral strategy. Curr. Pharm. Des. 2011;17:3898–3904. doi: 10.2174/138161211798357728. [DOI] [PubMed] [Google Scholar]
  • 34.Vlahos R., Stambas J., Bozinovski S., Broughton B.R., Drummond G.R., Selemidis S. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog. 2011;7:e1001271. doi: 10.1371/journal.ppat.1001271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.To E.E., Vlahos R., Luong R., Halls M.L., Reading P.C., King P.T., Chan C., Drummond G.R., Sobey C.G., Broughton B.R.S., et al. Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy. Nat. Commun. 2017;8:69. doi: 10.1038/s41467-017-00057-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Khomich O.A., Kochetkov S.N., Bartosch B., Ivanov A.V. Redox biology of respiratory viral infections. Viruses. 2018;10:392. doi: 10.3390/v10080392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Bizzarri B.M., Botta L., Capecchi E., Celestino I., Checconi P., Palamara A.T., Nencioni L., Saladino R. Regioselective IBX-mediated synthesis of coumarin derivatives with antioxidant and anti-influenza activities. J. Nat. Prod. 2017;80:3248–3255. doi: 10.1021/acs.jnatprod.7b00665. [DOI] [PubMed] [Google Scholar]
  • 38.Akaike T., Maeda H. Nitric oxide and virus infection. Immunology. 2000;101:300–308. doi: 10.1046/j.1365-2567.2000.00142.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Oda T., Akaike T., Hamamoto T., Suzuki F., Hirano T., Maeda H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science. 1989;244:974–976. doi: 10.1126/science.2543070. [DOI] [PubMed] [Google Scholar]
  • 40.Palamara A.T., Perno C.F., Ciriolo M.R., Dini L., Balestra E., D’Agostini C., Di Francesco P., Favalli C., Rotilio G., Garaci E. Evidence for antiviral activity of glutathione: In vitro inhibition of herpes simplex virus type 1 replication. Antivir. Res. 1995;27:237–253. doi: 10.1016/0166-3542(95)00008-A. [DOI] [PubMed] [Google Scholar]
  • 41.Palamara A.T., Perno C.F., Aquaro S., Bue M.C., Dini L., Garaci E. Glutathione inhibits HIV replication by acting at late stages of the virus life cycle. AIDS Res. Hum. Retrovir. 1996;12:1537–1541. doi: 10.1089/aid.1996.12.1537. [DOI] [PubMed] [Google Scholar]
  • 42.Ciriolo M.R., Palamara A.T., Incerpi S., Lafavia E., Bue M.C., De Vito P., Garaci E., Rotilio G. Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection. J. Biol. Chem. 1997;272:2700–2708. doi: 10.1074/jbc.272.5.2700. [DOI] [PubMed] [Google Scholar]
  • 43.Garaci E., Palamara A.T., Ciriolo M.R., D’Agostini C., Abdel-Latif M.S., Aquaro S., Lafavia E., Rotilio G. Intracellular GSH content and HIV replication in human macrophages. J. Leukoc. Biol. 1997;62:54–59. doi: 10.1002/jlb.62.1.54. [DOI] [PubMed] [Google Scholar]
  • 44.Herzenberg L.A., De Rosa S.C., Dubs J.G., Roederer M., Anderson M.T., Ela S.W., Deresinski S.C., Herzenberg L.A. Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. USA. 1997;94:1967–1972. doi: 10.1073/pnas.94.5.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Checconi P., Sgarbanti R., Celestino I., Limongi D., Amatore D., Iuvara A., Alimonti A., Garaci E., Palamara A.T., Nencioni L. The environmental pollutant cadmium promotes influenza virus replication in MDCK cells by altering their redox state. Int. J. Mol. Sci. 2013;14:4148–4162. doi: 10.3390/ijms14024148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Amatore D., Sgarbanti R., Aquilano K., Baldelli S., Limongi D., Civitelli L., Nencioni L., Garaci E., Ciriolo M.R., Palamara A.T. Influenza virus replication in lung epithelial cells depends on redox-sensitive pathways activated by NOX4-derived ROS. Cell. Microbiol. 2015;17:131–145. doi: 10.1111/cmi.12343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Davis D.A., Dorsey K., Wingfield P.T., Stahl S.J., Kaufman J., Fales H.M., Levine R.L. Regulation of HIV-1 protease activity through cysteine modification. Biochemistry. 1996;35:2482–2488. doi: 10.1021/bi951525k. [DOI] [PubMed] [Google Scholar]
  • 48.Davis D.A., Newcomb F.M., Starke D.W., Ott D.E., Mieyal J.J., Yarchoan R. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J. Biol. Chem. 1997;272:25935–25940. doi: 10.1074/jbc.272.41.25935. [DOI] [PubMed] [Google Scholar]
  • 49.Davis D.A., Yusa K., Gillim L.A., Newcomb F.M., Mitsuya H., Yarchoan R. Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions. J. Virol. 1999;73:1156–1164. doi: 10.1128/jvi.73.2.1156-1164.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Davis D.A., Brown C.A., Newcomb F.M., Boja E.S., Fales H.M., Kaufman J., Stahl S.J., Wingfield P., Yarchoan R. Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation. J. Virol. 2003;77:3319–3325. doi: 10.1128/JVI.77.5.3319-3325.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Saisawang C., Kuadkitkan A., Smith D.R., Ubol S., Ketterman A.J. Glutathionylation of chikungunya nsP2 protein affects protease activity. Biochim. Biophys. Acta. 2017;1861:106–111. doi: 10.1016/j.bbagen.2016.10.024. [DOI] [PubMed] [Google Scholar]
  • 52.Saisawang C., Kuadkitkan A., Auewarakul P., Smith D.R., Ketterman A.J. Glutathionylation of dengue and Zika NS5 proteins affects guanylyltransferase and RNA dependent RNA polymerase activities. PLoS ONE. 2018;13:e0193133. doi: 10.1371/journal.pone.0193133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Go Y.M., Jones D.P. The redox proteome. J. Biol. Chem. 2013;288:26512–26520. doi: 10.1074/jbc.R113.464131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Ghezzi P., Romines B., Fratelli M., Eberini I., Gianazza E., Casagrande S., Laragione T., Mengozzi M., Herzenberg L.A., Herzenberg L.A. Protein glutathionylation: Coupling and uncoupling of glutathione to protein thiol groups in lymphocytes under oxidative stress and HIV infection. Mol. Immunol. 2002;38:773–780. doi: 10.1016/S0161-5890(01)00114-6. [DOI] [PubMed] [Google Scholar]
  • 55.Prinarakis E., Chantzoura E., Thanos D., Spyrou G. S-glutathionylation of IRF3 regulates IRF3-CBP interaction and activation of the IFN beta pathway. EMBO J. 2008;27:865–875. doi: 10.1038/emboj.2008.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Gonzalez-Dosal R., Horan K.A., Rahbek S.H., Ichijo H., Chen Z.J., Mieyal J.J., Hartmann R., Paludan S.R. HSV infection induces production of ROS, which potentiate signaling from pattern recognition receptors: Role for S-glutathionylation of TRAF3 and 6. PLoS Pathog. 2011;7:e1002250. doi: 10.1371/journal.ppat.1002250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Go Y.M., Chandler J.D., Jones D.P. The cysteine proteome. Free Radic. Biol. Med. 2015;84:227–245. doi: 10.1016/j.freeradbiomed.2015.03.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Salzano S., Checconi P., Hanschmann E.M., Lillig C.H., Bowler L.D., Chan P., Vaudry D., Mengozzi M., Coppo L., Sacre S., et al. Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal. Proc. Natl. Acad. Sci. USA. 2014;111:12157–12162. doi: 10.1073/pnas.1401712111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Yamada Y., Limmon G.V., Zheng D., Li N., Li L., Yin L., Chow V.T., Chen J., Engelward B.P. Major shifts in the spatio-temporal distribution of lung antioxidant enzymes during influenza pneumonia. PLoS ONE. 2012;7:e31494. doi: 10.1371/journal.pone.0031494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Nakamura H., De Rosa S., Roederer M., Anderson M.T., Dubs J.G., Yodoi J., Holmgren A., Herzenberg L.A., Herzenberg L.A. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int. Immunol. 1996;8:603–611. doi: 10.1093/intimm/8.4.603. [DOI] [PubMed] [Google Scholar]
  • 61.Bertini R., Howard O.M., Dong H.F., Oppenheim J.J., Bizzarri C., Sergi R., Caselli G., Pagliei S., Romines B., Wilshire J.A., et al. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J. Exp. Med. 1999;189:1783–1789. doi: 10.1084/jem.189.11.1783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Go Y.M., Kang S.M., Roede J.R., Orr M., Jones D.P. Increased inflammatory signaling and lethality of influenza H1N1 by nuclear thioredoxin-1. PLoS ONE. 2011;6:e18918. doi: 10.1371/journal.pone.0018918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Nakamura H., Tamura S., Watanabe I., Iwasaki T., Yodoi J. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol. Lett. 2002;82:165–170. doi: 10.1016/S0165-2478(02)00033-0. [DOI] [PubMed] [Google Scholar]
  • 64.Yashiro M., Tsukahara H., Matsukawa A., Yamada M., Fujii Y., Nagaoka Y., Tsuge M., Yamashita N., Ito T., Yamada M., et al. Redox-active protein thioredoxin-1 administration ameliorates influenza A virus (H1N1)-induced acute lung injury in mice. Crit. Care Med. 2013;41:171–181. doi: 10.1097/CCM.0b013e3182676352. [DOI] [PubMed] [Google Scholar]
  • 65.Tanaka R., Ishima Y., Enoki Y., Kimachi K., Shirai T., Watanabe H., Chuang V.T., Maruyama T., Otagiri M. Therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury mice. Front. Immunol. 2014;5:561. doi: 10.3389/fimmu.2014.00561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Go Y.M., Jones D.P. Redox compartmentalization in eukaryotic cells. Biochim. Biophys. Acta. 2008;1780:1273–1290. doi: 10.1016/j.bbagen.2008.01.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Trujillo J.A., Croft N.P., Dudek N.L., Channappanavar R., Theodossis A., Webb A.I., Dunstone M.A., Illing P.T., Butler N.S., Fett C., et al. The cellular redox environment alters antigen presentation. J. Biol. Chem. 2014;289:27979–27991. doi: 10.1074/jbc.M114.573402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Loi V.V., Rossius M., Antelmann H. Redox regulation by reversible protein S-thiolation in bacteria. Front. Microbiol. 2015;6:187. doi: 10.3389/fmicb.2015.00187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Reniere M.L., Whiteley A.T., Hamilton K.L., John S.M., Lauer P., Brennan R.G., Portnoy D.A. Glutathione activates virulence gene expression of an intracellular pathogen. Nature. 2015;517:170–173. doi: 10.1038/nature14029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Pother D.C., Gierok P., Harms M., Mostertz J., Hochgrafe F., Antelmann H., Hamilton C.J., Borovok I., Lalk M., Aharonowitz Y., et al. Distribution and infection-related functions of bacillithiol in Staphylococcus aureus. Int. J. Med. Microbiol. 2013;303:114–123. doi: 10.1016/j.ijmm.2013.01.003. [DOI] [PubMed] [Google Scholar]
  • 71.Posada A.C., Kolar S.L., Dusi R.G., Francois P., Roberts A.A., Hamilton C.J., Liu G.Y., Cheung A. Importance of bacillithiol in the oxidative stress response of staphylococcus aureus. Infect. Immun. 2014;82:316–332. doi: 10.1128/IAI.01074-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Sassetti C.M., Rubin E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA. 2003;100:12989–12994. doi: 10.1073/pnas.2134250100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Ansong C., Wu S., Meng D., Liu X., Brewer H.M., Deatherage Kaiser B.L., Nakayasu E.S., Cort J.R., Pevzner P., Smith R.D., et al. Top-down proteomics reveals a unique protein S-thiolation switch in Salmonella Typhimurium in response to infection-like conditions. Proc. Natl. Acad. Sci. USA. 2013;110:10153–10158. doi: 10.1073/pnas.1221210110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Portman J.L., Huang Q.Y., Reniere M.L., Iavarone A.T., Portnoy D.A. Activity of the pore-forming virulence factor listeriolysin O is reversibly inhibited by naturally occurring S-glutathionylation. Infect. Immun. 2017;85:e00959-16. doi: 10.1128/IAI.00959-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Anathy V., Aesif S.W., Guala A.S., Havermans M., Reynaert N.L., Ho Y.S., Budd R.C., Janssen-Heininger Y.M. Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of Fas. J. Cell Biol. 2009;184:241–252. doi: 10.1083/jcb.200807019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Anathy V., Aesif S.W., Hoffman S.M., Bement J.L., Guala A.S., Lahue K.G., Leclair L.W., Suratt B.T., Cool C.D., Wargo M.J., et al. Glutaredoxin-1 attenuates S-glutathionylation of the death receptor fas and decreases resolution of Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 2014;189:463–474. doi: 10.1164/rccm.201310-1905OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Kerstholt M., Vrijmoeth H., Lachmandas E., Oosting M., Lupse M., Flonta M., Dinarello C.A., Netea M.G., Joosten L.A.B. Role of glutathione metabolism in host defense against Borrelia burgdorferi infection. Proc. Natl. Acad. Sci. USA. 2018;115:E2320–E2328. doi: 10.1073/pnas.1720833115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Klatt P., Molina E.P., De Lacoba M.G., Padilla C.A., Martinez-Galesteo E., Barcena J.A., Lamas S. Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J. 1999;13:1481–1490. doi: 10.1096/fasebj.13.12.1481. [DOI] [PubMed] [Google Scholar]
  • 79.Qanungo S., Starke D.W., Pai H.V., Mieyal J.J., Nieminen A.L. Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFkappaB. J. Biol. Chem. 2007;282:18427–18436. doi: 10.1074/jbc.M610934200. [DOI] [PubMed] [Google Scholar]
  • 80.Liao B.C., Hsieh C.W., Lin Y.C., Wung B.S. The glutaredoxin/glutathione system modulates NF-kappaB activity by glutathionylation of p65 in cinnamaldehyde-treated endothelial cells. Toxicol. Sci. 2010;116:151–163. doi: 10.1093/toxsci/kfq098. [DOI] [PubMed] [Google Scholar]
  • 81.Lin Y.C., Huang G.D., Hsieh C.W., Wung B.S. The glutathionylation of p65 modulates NF-kappa B activity in 15-deoxy-Delta,(12,14)-prostaglandin J(2)-treated endothelial cells. Free Radic. Biol. Med. 2012;52:1844–1853. doi: 10.1016/j.freeradbiomed.2012.02.028. [DOI] [PubMed] [Google Scholar]
  • 82.Alisi A., Pastore A., Passarelli C., Tozzi G., Bottazzo G.F., Nobili V., Piemonte F. Glutathionylation of p65NF-KB correlates with proliferating/apoptotic hepatoma cells exposed to pro- and anti-oxidants. Free Radic. Res. 2009;43:59. doi: 10.3892/ijmm_00000235. [DOI] [PubMed] [Google Scholar]
  • 83.Pineda-Molina E., Klatt P., Vazquez J., Marina A., de Lacoba M.G., Perez-Sala D., Lamas S. Glutathionylation of the p50 subunit of NF-kappa B: A mechanism for redox-induced inhibition of DNA binding. Biochemistry. 2001;40:14134–14142. doi: 10.1021/bi011459o. [DOI] [PubMed] [Google Scholar]
  • 84.Reynaert N.L., van der Vliet A., Guala A.S., McGovern T., Hristova M., Pantano C., Heintz N.H., Heim J., Ho Y.S., Matthews D.E., et al. Dynamic redox control of NF-kappa B through glutaredoxin-regulated S-glutathionylation of inhibitory kappa B kinase beta. Proc. Natl. Acad. Sci. USA. 2006;103:13086–13091. doi: 10.1073/pnas.0603290103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Chantzoura E., Prinarakis E., Panagopoulos D., Mosialos G., Spyrou G. Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signalling. Biochem. Biophys. Res. Commun. 2010;403:335–339. doi: 10.1016/j.bbrc.2010.11.029. [DOI] [PubMed] [Google Scholar]
  • 86.Nolin J.D., Tully J.E., Hoffman S.M., Guala A.S., van der Velden J.L., Poynter M.E., van der Vliet A., Anathy V., Janssen-Heininger Y.M. The glutaredoxin/S-glutathionylation axis regulates interleukin-17A-induced proinflammatory responses in lung epithelial cells in association with S-glutathionylation of nuclear factor kappaB family proteins. Free Radic. Biol. Med. 2014;73:143–153. doi: 10.1016/j.freeradbiomed.2014.04.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Jones J.T., Qian X., van der Velden J.L.J., Chia S.B., McMillan D.H., Flemer S., Hoffman S.M., Lahue K.G., Schneider R.W., Nolin J.D., et al. Glutathione S-transferase pi modulates NF-kappa B activation and pro-inflammatory responses in lung epithelial cells. Redox Biol. 2016;8:375–382. doi: 10.1016/j.redox.2016.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Zhang X., Liu P., Zhang C., Chiewchengchol D., Zhao F., Yu H., Li J., Kambara H., Luo K.Y., Venkataraman A., et al. Positive regulation of interleukin-1beta bioactivity by physiological ROS-mediated cysteine S-glutathionylation. Cell Rep. 2017;20:224–235. doi: 10.1016/j.celrep.2017.05.070. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nutrients are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES